Skip to main content
Signal8

Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced through Phase III clinical trials for psoriasis and completed Phase II trials for COVID-19. Another promising asset, Namodenoson, is currently undergoing Phase III clinical evaluation for hepatocellular carcinoma (a form of liver cancer) and is in a Phase IIb study for non-alcoholic steatohepatitis (NASH). Furthermore, CF602 is in preclinical development, aimed at addressing erectile dysfunction. Beyond its drug pipeline, Can-Fite also commercializes a predictive biomarker blood test kit for A3AR. Strategic partnerships are also key to its operations; a licensing and collaboration agreement with CMS Medical covers the development, manufacturing, and commercialization of both Piclidenoson and Namodenoson. Additionally, the company collaborates with Univo Pharmaceuticals to identify and co-develop cannabis-derived formulations intended for various therapeutic applications, including cancer, inflammatory, autoimmune, and metabolic conditions. Originally incorporated in 1994 as Can-Fite Technologies Ltd., the company adopted its current name, Can-Fite BioPharma Ltd., in January 2001 and is headquartered in Petah Tikva, Israel.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd.

NYSE:CANFHealthcare
-2.41%$1.62
AH$1.62+0.00%vs close
Mkt Cap$4.91M
Float1.31M
O/S3.03M
Vol
$ Vol
RVOL
Inst Own1.9%
SI2.6%
Earnings
Dilution
Financials Summary
Revenue$408K
Net Income-$9.91M
Total Assets$9.51M
Free Cash Flow-$9.02M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$71K
Total Equity$5.59M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:20

Nasdaq bars a compliance period at 1:250

  1. 1:20Reverse split
    Jan 5, 202620 shares → 1
  2. 1:10Reverse split
    Jan 9, 202310 shares → 1
  3. 1:15Reverse split
    May 10, 201915 shares → 1
Balance Sheet Details
Assets$9.51M
Liabilities$3.92M
Accounts Receivable$74K
Accounts Payable$1.16M
Inventory$0
PP&E (Net)$74K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue$408K$674K$743K$810K$853K$763K$2.03M$3.82M$845K$170K$165K$0$0$0$469K$745K
YoY Growth-39.4%-9.3%-8.3%-5.0%11.8%-62.5%-46.8%352.2%398.4%2.9%-----37.1%-
Cost of Revenue$24K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Gross Profit$384K$674K$743K$810K$853K$763K$2.03M$3.82M$845K$170K$165K$0$0$0$469K$745K
Gross Margin94.1%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%---100.0%100.0%
Research and Development$6.75M$5.76M$5.98M$7.76M$9.85M$11.95M$10.98M$6.08M$5.27M$6.08M$3.86M$4.16M$4.42M$3.52M$3.41M$2.82M
Selling, General, and Administrative$3.67M$3.05M$2.96M$3.14M$3.85M$2.95M$3.06M$3.16M$2.95M$2.7M$2.7M$2.94M$4.52M$2.48M$1.86M$1.69M
Other$0$0$0$0$0$0$0$0$31K$29K$24K$32K$53K-$0-$0$0
Total Operating Expenses$10.41M$8.8M$8.94M$10.91M$13.7M$14.9M$14.04M$9.23M$8.22M$8.8M$6.58M$7.13M$8.99M$6M$5.27M$4.51M
Operating Income (EBIT)-$10.03M-$8.13M-$8.2M-$10.1M-$12.84M-$14.14M-$12.01M-$5.41M-$7.38M-$8.63M-$6.42M-$7.13M-$8.99M-$5.99M-$4.78M-$3.76M
Operating Margin-2456.8%-1206.2%-1103.0%-1246.4%-1505.5%-1853.1%-590.9%-141.7%-873.1%-5093.7%-3894.6%----1018.3%-505.1%
Interest Expense$14K$14K$14K$77K$18K$363K$427K$1.2M$1.1M$27K$564K$15K$16K$7K$378K$7K
Interest Income$286K$291K$506K$222K$24K$44K$72K$51K$2.99M$89K$1.92M$12K$26K$13K$439K$31K
Other Income (Expense)$123K$250K$561K-$77K$227K-$304K-$618K-$1.15M$781K$270K$1.35M$840K$146K$138K-$2.63M$152K
Income Before Tax (EBT)-$9.91M-$7.88M-$7.63M-$10.17M-$12.62M-$14.44M-$12.63M-$6.57M-$4.95M-$6.99M-$5.06M-$6.29M-$8.85M-$5.86M-$7.42M-$3.61M
Income Tax Expense$0$0$0$360K-$20K$0$427K$4K$30K$29K$4K$6K$3K$3K$50K$66K
Net Income-$9.91M-$7.88M-$7.63M-$10.17M-$12.6M-$14.44M-$12.63M-$6.57M-$4.97M-$6.9M-$4.8M-$6.1M-$8.34M-$5.57M-$6.7M-$3.68M
Net Income Margin-2426.7%-1169.1%-1027.5%-1255.9%-1476.6%-1892.9%-621.3%-172.0%-588.2%-4069.3%-2912.3%----1428.5%-493.5%
Supplementary Data
EPS-0.08-0.01-0.01-0.03-0.06-0.08-0.30-0.34-0.38-0.60-0.54-0.70-1.22-1.12-1.44-0.84
Diluted EPS-0.08-0.01-0.01-0.03-0.06-0.08-0.30-0.34-0.38-0.60-0.54-0.70-1.22-1.12-1.44-0.84
Weighted Average OS123.59M1.09B639.17M407.87M229.44M170.75M42.95M19.45M16.26M13.85M11.48M8.77M6.86M5.03M4.68M4.34M
EBITDA-$10M-$8.12M-$8.18M-$10.08M-$12.83M-$14.13M-$11.99M-$6.13M-$7.17M-$8.68M-$6.4M-$7.12M-$9.01M-$5.98M-$7.33M-$3.53M
EBITDA Margin-2450.9%-1205.2%-1100.9%-1244.7%-1503.9%-1851.5%-590.2%-160.4%-848.3%-5119.2%-3884.6%----1563.5%-473.1%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$5.53M$4.83M$4.28M$2.98M$4.39M$8.27M$2.7M$3.62M$3.5M$8.11M$16.91M$9.27M$5.96M$1.15M$3.84M
Short-Term Investments$3.01M$3.06M$4.64M$5M$14.75M$75K$64K$273K$0$0$0$0$0$0$0
Cash and Short-Term Investments$8.54M$7.89M$8.92M$7.98M$19.14M$8.34M$2.76M$3.89M$3.5M$8.11M$16.91M$9.27M$5.96M$1.15M$3.84M
Accounts Receivable$74K$0$0$47K$48K$18K$637K$0$0$22K$62K$0$58K$0$98K
Inventory$0$0$0-$39K-$48K$0-$715K-$3.97M-$3.3M$0-$621K$0-$623K$0$1
Other Current Assets$826K$1.09M$78K$47K$48K$0$729K$41K$0$0$559K$808K$565K$415K-$0
Total Current Assets$9.44M$8.98M$9.91M$9.16M$20.07M$9.4M$7.14M$7.9M$6.87M$10.1M$17.53M$10.15M$6.58M$1.59M$4.83M
Long-Term Assets
Property, Plant & Equipment Net$74K$138K$81K$126K$185K$123K$118K$47K$46K$53K$60K$34K$41K$43K$73K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$8K$0$0$0$0$915K$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$8K$0$0$912K$2K$5K$10K$7K$7K$10K$0$0
Total Long-Term Assets$74K$138K$81K$126K$185K$123K$1.03M$49K$966K$63K$67K$41K$51K$43K$73K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$9.51M$9.12M$9.99M$9.28M$20.25M$9.52M$8.17M$7.95M$7.83M$10.17M$17.6M$10.19M$6.63M$1.64M$4.9M
Liabilities
Current Liabilities
Accounts Payable$1.16M$618K$427K$896K$954K$561K$2.16M$1.07M$427K$1.25M$462K$263K$590K$1.98M$507K
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$405K$405K$622K$783K$818K$334K$469K$926K$374K$322K$220K$0$0$0$0
Other Current Liabilities$298K$675K$694K$492K$603K$96K$165K$149K$268K$669K$149K$249K$317K-$728K$298K
Total Current Liabilities$2.73M$2.05M$2.02M$2.5M$2.73M$1.27M$3.27M$3.12M$1.8M$2.5M$1.78M$1.48M$2.14M$2.32M$1.35M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$1.18M$1.58M$1.71M$2.29M$3.07M$2.16M$2.42M$1.82M$956K$1.17M$933K$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0-$2.29M-$3.07M-$2.16M-$2.42M$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$2.29M$3.07M$2.16M$1.57M$0$2.14M$2.62M$4.45M$1.85M$37K$18K$258K
Total Long-Term Liabilities$1.19M$1.63M$1.73M$2.31M$3.14M$2.18M$2.46M$1.82M$2.98M$3.79M$5.38M$1.85M$37K$18K$258K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$3.92M$3.68M$3.75M$4.81M$5.87M$3.45M$5.73M$4.94M$4.78M$6.29M$7.16M$3.33M$2.18M$2.34M$1.61M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$1$0$0$0
Common Stock$0$0$0$0$60.65M$33.04M$8.22M$2.63M$2.39M$1.83M$1.8M$1.4M$1.16M$732K$685K
Retained Earnings-$176.19M-$166.36M-$158.48M-$150.85M-$140.67M-$125.47M-$110.31M-$100.62M-$105.66M-$90.98M-$82.71M-$78.11M-$80.51M-$67.28M-$60.85M
Comprehensive Income & Other$1.13M$1.13M$1.13M$1.13M$1.13M$1.13M$1.13M$6.93M$6.28M$5.08M$4.58M$4.14M$4.48M$4.11M$3.87M
Other Stockholders' Equity$181.78M$171.8M$164.72M$155.32M$94.4M$98.51M$104.53M$101M$106.32M$93.01M$91.23M$83.19M$83.15M$65.31M$62.87M
Total Equity$5.59M$5.44M$6.24M$4.47M$14.38M$6.07M$2.44M$3.02M$3.05M$3.87M$10.32M$6.48M$3.8M-$1.24M$2.71M
Minority Interest$0$0$0$0$0$0$0$0$0$9K$129K$375K$660K$535K$584K
Total Liabilities and Equity$9.51M$9.12M$9.99M$9.28M$20.25M$9.52M$8.17M$7.95M$7.83M$10.16M$17.47M$9.81M$5.97M$1.1M$4.32M
Supplementary Data
Total Debt$71K$104K$40K$62K$124K$67K$75K$0$0$0$0$0$0$0$0
Net Debt-$5.46M-$4.72M-$4.24M-$2.92M-$4.27M-$8.2M-$2.62M-$3.62M-$3.5M-$8.11M-$16.91M-$9.27M-$5.96M-$1.15M-$3.84M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Operating Activities
Net Income-$9.83M-$7.88M-$7.63M-$10.17M-$12.62M-$14.44M-$12.63M-$6.57M-$4.98M-$7.02M-$5.06M-$6.3M-$8.85M-$5.86M-$7.47M-$3.68M
Depreciation & Amortization$24K$7K$15K$14K$14K$12K$14K$14K$20K$18K$16K$12K$17K$23K$57K$79K
Deferred Income Tax$0$0$0$0-$94K$11K$212K$0$279K$0$0$0-$153K-$92K-$35K$95K
Stock-Based Compensation$340K$362K$261K$263K$466K$355K$385K$535K$195K$309K$109K$212K$788K$390K$84K$177K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$2.73M$270K-$853K-$1.16M-$1.37M$255K-$303K-$159K$559K$0-$29K
  Inventory$0$0$0$0$0$1.27M-$316K$125K-$0$0$0$0$0$0$0$0
  Accounts Payable$547K$191K-$469K-$58K$393K-$1.59M$1.08M$644K-$964K$592K$79K-$658K-$72K$747K$177K-$110K
  Other Working Capital-$111K-$458K-$474K-$1.24M$2.04M-$401K$146K$1.22M-$323K$325K$1.15M-$0$149K$0-$843K$0
Total Working Capital Change$436K-$267K-$943K-$1.3M$2.43M$2M$1.19M$1.13M-$2.45M-$449K$1.49M-$962K-$231K$1.31M-$667K-$138K
Other Non-Cash Items$7K$141K-$139K$396K-$59K$1K-$5K$733K-$2.59M-$1.47M-$1.09M-$80K-$203K-$117K$2.53M-$190K
Net Cash from Operating-$9.02M-$7.64M-$8.44M-$10.8M-$9.86M-$12.06M-$10.83M-$4.16M-$9.52M-$8.93M-$4.65M-$7.33M-$8.63M-$4.35M-$5.5M-$3.65M
Investing Activities
Capital Expenditures-$2K-$5K-$2K-$9K-$11K-$26K-$3K-$33K-$7K-$10K-$45K-$10K-$12K-$5K-$21K-$30K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0-$14.5M$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0-$23K$0$0$0$0$0$0$0
Other Investing Activities$0$1.5M$500K$9.51M$0$0-$250K$0-$22K$0$3K$0$2K$25K$43K$0
Net Cash from Investing-$2K$1.5M$498K$9.5M-$14.51M-$26K-$253K-$33K-$30K-$10K-$43K-$10K-$10K$20K$22K-$30K
Financing Activities
Debt Repaid------$34K---------
Common Stock Issuance$9.72M$6.71M$9.14M$0$20.46M$17.68M$10.17M$4.39M$4.47M$0$12.38M$11.47M$13.18M$1.43M$4.23M$3.08M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$0$34K$0$0$0$0$0$37K$68K$410K$303K
Net Cash from Financing$9.72M$6.71M$9.14M$0$20.46M$17.68M$10.17M$4.39M$4.88M$0$12.38M$11.47M$13.22M$1.5M$4.64M$3.38M
Forex Effect$4K-$22K$98K-$113K$34K-$23K$2K-$89K-$812K-$115K-$19K-$201K$161K$60K$72K-$118K
Net Change in Cash$703K$547K$1.3M-$1.41M-$3.88M$5.57M-$918K$110K-$5.48M-$9.05M$7.67M$3.94M$4.73M-$2.77M-$758K-$419K
Supplementary Data
Operating Cash Flow-$9.02M-$7.64M-$8.44M-$10.8M-$9.86M-$12.06M-$10.83M-$4.16M-$9.52M-$8.93M-$4.65M-$7.33M-$8.63M-$4.35M-$5.5M-$3.65M
Capital Expenditure-$2K-$5K-$2K-$9K-$11K-$26K-$3K-$33K-$7K-$10K-$45K-$10K-$12K-$5K-$21K-$30K
Free Cash Flow-$9.02M-$7.64M-$8.44M-$10.81M-$9.87M-$12.09M-$10.84M-$4.19M-$9.53M-$8.94M-$4.7M-$7.34M-$8.64M-$4.35M-$5.52M-$3.68M
Cash at Beginning$4.82M$4.28M$2.98M$4.39M$8.27M$2.7M$3.62M$3.5M$8.98M$17.16M$9.25M$5.33M$1.23M$3.91M$4.6M$5.35M
Cash at End$5.53M$4.83M$4.28M$2.98M$4.39M$8.27M$2.7M$3.62M$3.5M$8.11M$16.91M$9.27M$5.96M$1.15M$3.84M$4.93M